Federal Appeals Court rules that Biosimilars Act preempts state law

In a ruling issued in the case of Amgen Inc. v. Sandoz Inc. concerning biosimilars, the U.S. Court of Appeals for the Federal Circuit (CAFC) held that the federal Biologics

Read the full 309 word article

User Sign In